To Determine the Accuracy of SCreening for Occult REnal Disease (SCORED) Questionnaire for CKD Risk Among Asian Patients
Completed
- Conditions
- Chronic Kidney Disease
- Registration Number
- NCT05866276
- Lead Sponsor
- AstraZeneca
- Brief Summary
To determine the accuracy of SCreening for Occult REnal Disease (SCORED) questionnaire for CKD risk among Asian Patients
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1426
Inclusion Criteria
Exclusion Criteria
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sensitivity and Specificity 28 February 2024 The primary objective is to evaluate the accuracy of SCORED tool in identifying individuals at risk for the development of CKD in the Asian population. The primary outcomes, sensitivity, and specificity will be summarised using percentage and 95% confidence intervals to be measured at Baseline up to 6months after enrollment
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (3)
Research Site
🇮🇩Surabaya, Indonesia
Perisai Husada
🇮🇩Bandung, Jawa Barat, Indonesia
Nguyen Tri Phuong Hospital
🇻🇳Ho Chi Minh City, Vietnam